Bleeding, Transfusion, and Mortality on Extracorporeal Life Support: ECLS Working Group on Thrombosis and Hemostasis Michael Mazzeffi, MD, MPH, John Greenwood, MD, Kenichi Tanaka, MD, MS, Jay Menaker, MD, Raymond Rector, CCP, Daniel Herr, MD, Zachary Kon, MD, Joy Lee, BS, Bartley Griffith, MD, Keshava Rajagopal, MD, PhD, Si Pham, MD The Annals of Thoracic Surgery Volume 101, Issue 2, Pages 682-689 (February 2016) DOI: 10.1016/j.athoracsur.2015.07.046 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Kaplan-Meier survival analysis for the cohort. (Blue line = no bleeding event; green line = bleeding event; hatch marks = censored.) The Annals of Thoracic Surgery 2016 101, 682-689DOI: (10.1016/j.athoracsur.2015.07.046) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Kaplan-Meier survival analysis for patients who had venoarterial extracorporeal life support. (Blue line = no bleeding event; green line = bleeding event; hatch marks = censored.) The Annals of Thoracic Surgery 2016 101, 682-689DOI: (10.1016/j.athoracsur.2015.07.046) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier survival analysis for patients who had venovenous extracorporeal life support. (Blue line = no bleeding event; green line = bleeding event; hatch marks = censored.) The Annals of Thoracic Surgery 2016 101, 682-689DOI: (10.1016/j.athoracsur.2015.07.046) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions